-
Something wrong with this record ?
Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation
K. Kovacovicova, M. Vinciguerra,
Language English Country Great Britain
Document type Journal Article
Grant support
CZ.02.1.01/0.0/0.0/15_003/0000492
European Social Fund and European Regional Development Fund
European Social Fund
European Regional Development Fund
NLK
Directory of Open Access Journals
from 2019
PubMed Central
from 1997
ProQuest Central
from 2019-01-01
Medline Complete (EBSCOhost)
from 1998-02-01
Wiley-Blackwell Open Access Titles
from 2019
ROAD: Directory of Open Access Scholarly Resources
from 1991
PubMed
31517418
DOI
10.1111/cpr.12674
Knihovny.cz E-resources
- MeSH
- Doxorubicin pharmacology MeSH
- Carcinoma, Hepatocellular pathology MeSH
- Triiodobenzoic Acids pharmacology MeSH
- Humans MeSH
- Liver Neoplasms pathology MeSH
- DNA Damage drug effects MeSH
- Cell Separation * methods MeSH
- Cellular Senescence drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: Chemotherapeutic drugs induce senescence in cancer cells but, unlike replicative senescence or oncogene-induced senescence, do so rather inefficiently and depending on DNA damage. A thorough understanding of the biology of chemotherapy-induced senescent cells requires their isolation from a mixed population of adjacent senescent and non-senescent cancer cells. MATERIALS AND METHODS: We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro. RESULTS: After cellular exposure to DXR, we used iodixanol gradient-based centrifugation to isolate and re-plate cells on collagen-coated flasks, despite their low or null proliferative capacity. The isolated cell populations were enriched for DXR-induced senescent HCC cells, as confirmed by proliferation arrest assay, and β-galactosidase and DNA damage-dependent γH2A.X staining. CONCLUSIONS: Analysing pure cultures of chemotherapy-induced senescent versus non-responsive cancer cells will increase our knowledge on chemotherapeutic mechanisms of action, and help refine current therapeutic strategies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044534
- 003
- CZ-PrNML
- 005
- 20200113105444.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cpr.12674 $2 doi
- 035 __
- $a (PubMed)31517418
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kovacovicova, Kristina $u Center for Translational Medicine, International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.
- 245 10
- $a Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation / $c K. Kovacovicova, M. Vinciguerra,
- 520 9_
- $a OBJECTIVES: Chemotherapeutic drugs induce senescence in cancer cells but, unlike replicative senescence or oncogene-induced senescence, do so rather inefficiently and depending on DNA damage. A thorough understanding of the biology of chemotherapy-induced senescent cells requires their isolation from a mixed population of adjacent senescent and non-senescent cancer cells. MATERIALS AND METHODS: We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro. RESULTS: After cellular exposure to DXR, we used iodixanol gradient-based centrifugation to isolate and re-plate cells on collagen-coated flasks, despite their low or null proliferative capacity. The isolated cell populations were enriched for DXR-induced senescent HCC cells, as confirmed by proliferation arrest assay, and β-galactosidase and DNA damage-dependent γH2A.X staining. CONCLUSIONS: Analysing pure cultures of chemotherapy-induced senescent versus non-responsive cancer cells will increase our knowledge on chemotherapeutic mechanisms of action, and help refine current therapeutic strategies.
- 650 _2
- $a hepatocelulární karcinom $x patologie $7 D006528
- 650 12
- $a separace buněk $x metody $7 D002469
- 650 _2
- $a stárnutí buněk $x účinky léků $7 D016922
- 650 _2
- $a poškození DNA $x účinky léků $7 D004249
- 650 _2
- $a doxorubicin $x farmakologie $7 D004317
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory jater $x patologie $7 D008113
- 650 _2
- $a kyseliny trijodbenzoové $x farmakologie $7 D014283
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vinciguerra, Manlio $u Center for Translational Medicine, International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.
- 773 0_
- $w MED00001074 $t Cell proliferation $x 1365-2184 $g Roč. 52, č. 6 (2019), s. e12674
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31517418 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113105816 $b ABA008
- 999 __
- $a ok $b bmc $g 1482803 $s 1083207
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 52 $c 6 $d e12674 $e 20190913 $i 1365-2184 $m Cell proliferation $n Cell Prolif $x MED00001074
- GRA __
- $a CZ.02.1.01/0.0/0.0/15_003/0000492 $p European Social Fund and European Regional Development Fund
- GRA __
- $p European Social Fund
- GRA __
- $p European Regional Development Fund
- LZP __
- $a Pubmed-20200109